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The bactericidal action of pulsed exposure to rifampicin (R), ethambutol (Emb), isoniazid (I) and
pyrazinamide (Z) togcthcr on alternate days (REmbIZ) and as REmb and IZ separately on alternate
days (REmb/IZ) on M.tuberculosis H 37Rv, two isolates of M.tuberculosis ensitive to these drugs, as
well as four isolates resistant to one or more drugs, was studied using an in vitro method. The
experimental duration was 6 days. REmbIZ and REmb/IZ appeared to have equally good bactericidal
action on M.tuberculosis trains in the in vitro system. The results suggest that splitting REmbIZ into
REmb and IZ on alternate days in short course chemotherapy regimens for tuberculosis may not affect
the bactericidal action of the regimens.
Several highly effective short course chemotherapy
(SCC) regimens of 6-8 months’ duration have been
evolved for the treatment of sputum-positive pulmo-
nary tuberculosis. In most of these regimens, four
drugs, viz.,rifampicin (R), isoniazid (I), pyrazinamide
(Z) and streptomycin (S) or ethambutol (Emb) are
given together, usually for two months initially, in a
single dose either daily or intermittently. The bulk of
the drugs to be consumed in a single dose is therefore
large and may affect patient compliance. Further, the
incidence of adverse reactions such as arthralgia1 and
jaundice2 is more when the drugs are given daily than
if given less frequently. One way of overcoming
these difficulties would be to split the four-drug
regimen into two, 2-drug combinations (REmb & IZ)
and to give them in an alternating regimen in which
each 2-drug combination is taken on successive days.
No information is, however, available as to whether
such an alternating regimen would be as effective as
when all 4 drugs are given together, 3 times a week.
In vitro studies can be used to examine the bacte-
ricidal action of such pulsed exposure to drugs on
Mycobacterium tuberculosis strains3,4. In the present
study, using an in vitro system, we investigated the
bactericidal action of pulsed exposure to combina-
tions of REmb and IZ on cultures of M. tuberculosis
H37Rv, isolates of M.tuberculosis sensitive to these
rugs, as well as isolates resistant to one or more
drugs.
Material & Methods
M.tub rcu1osis strains: Seven strains of M.tuber-
culosis including M. tuberculosis H37Rv, 2 clinical
isolates sensitive to S, I, R and Emb, 3 isolates
resistant to I, IR and SIR, respectively, and 1 isolate
resistant to SIREmb by minimum inhibitory concen-
tration (MIC) method on Lowenstein-Jensen (LJ)
slopes were used in the study.
Chemotherapeutic drugs: Ethambutol (Sigma, USA),
isoniazid (Bayer, Germany) and pyrazinamide
(Sigma, USA) were dissolved in sterile distilled wa-
ter. Rifampicin (Sigma, USA) solution was prepared
fresh each day by dissolving in minimum quantity of
N/10 HCl and immediately diluting to the required
concentration with sterile distilled water. All drug
solutions were sterilised by filtration through 0.22
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µm membrane filters (Millipore). R, Emb, I and Z
were added to universal containers with 10 ml log
phase cultures of the M.tuberculosis trains in
Middlebrook’s 7H9 liquid medium (Difco, USA)
with 0.05 per cent Tween 80 (Sigma, USA) and
albumin/dextrose enrichment. The final concentra-
tions of R, Emb, I and Z in 7H9 medium were 1, 4, 1
and 25 µg/ml, respectively. These concentrations were
not meant to be analogous to the peak concentrations
that will be attained in patients’ sera with the doses
normally employed5,6 because such concentrations
are not maintained throughout a 24h exposure in
patients. The concentrations used were meant to be as
low as possible without them being close to the
minimal inhibitory concentrations (Prof. D.A.
Mitchison, personal communication).
Log phase cultures of M. tuberculosis: The
M.tuberculosis strains were first grown in 50 ml of
7H9 medium for 7 days at 37°C, spun down at 3000
rpm for 30 min and resuspended in 10 ml of 7H9. The
total number of bacilli/ml in this suspension was
counted using the Thoma bacteriological counting
chamber (Gallenkamp, London) and appropriate vol-
ume was inoculated into 100 ml of fresh 7H9 medium
to give 105 bacilli/ml. These cultures were incubated
at 37°C for 3 days to bring them to log phase7 and
distributed into 10 ml aliquots in universal containers
(day  0).
Pulsed exposure to REmb/IZ and REmbIZ: Duplicate
10 ml aliquots were treated with pulsed exposure to
REmb on one day and 12 on the next day (REmb/IZ)
or REmbIZ together on alternate days (REmbIZ)
using a filtration and resuspension procedure.
In the ‘REmbIZ’ cultures, all the 4 drugs were
added on day 0. On day 2 and day 4 old medium with
the drugs was replaced with fresh medium by filter-
ing the cultures through 0.45 µm, 25 mm diameter
membrane filter (Millipore HAWP 02500) and holder
assembly (Millipore Swinnex SX 0002500) with a
syringe, following through twice with an equal
volume of sterile distilled water and then
resuspending the bacilli which were now deposited
on the membrane filter by removing and placing
the membrane in a universal container with two 5
mm sterile glass beads and 10 ml fresh 7H9
medium without drugs and shaking for 1h. The 4
drugs were then added again.
In the ‘REmb/IZ’ cultures, R and Emb were added
on day 0. Using the filtration and resuspension method
as above, this was replaced with fresh medium and IZ
on days 1, 3 and 5, and REmb on days 2 and 4.
Cultures which were not treated with any drugs
and l ft undisturbed (undisturbed controls) as well as
cul ures which were not treated with any drugs but
were ubjected to the same filtration and resuspension
procedure (filtered controls) as the cultures treated
with drugs, were also included as controls.
Viable counts: Viable counts were set up from all
the cultures on days 0, 2, 4 and 6, before the addi-
tion of drugs, by inoculating 10 µl of the neat cul-
tures and five serial 10-fold dilutions on duplicate
slopes of LJ. The LJ slopes were incubated at 37°C
f r 4 wk. From the number of colonies appearing on
the LJ slopes and the dilution factor, colony forming
units/ml (cfu/ml) was calculated. When there were
no detectable colonies on any of the slopes, to facili-
ta e handling of data, the cfu/ml was recorded as
0.25.
Centrifugation vs filtration for removal of drugs:
During the course of the pulsed exposure experiment,
the drugs in the culture medium have to be removed
at intervals when viable counts are set up and for
pulsing. To select and standardise a suitable method
for this, in addition to the filtration method, centrifu-
gation for 30 min at 3000 rpm in universal containers
following which the supernatant was discarded be-
fore resuspending the pellet in fresh medium, was
also tested in an experiment using M. tuberculosis
H37RV.
Analysis of data : The area under the curve (AUC)
was calculated by applying the trapezoidal rule for
the log cfu/ml in the filtered control (FC), and in the
cultures treated with REmbIZ and REmb/IZ, taking
(t e strains of M. tuberculosis individually. For this,
the cut off point was taken as 1.4 because that was the
mi imum detectable log cfu/ml in the system em-
ployed. The mean AUCs for the log cfu/ml of the 3
strains which were sensitive to S, I and R and for the
other 3 strains which were resistant to one or more of
these drugs were compared separately using paired t-
test (one-tail).
Table I. Serial viable counts of M.tuberculosis H37Rv subjected to filtration/centrifugation and resuspension
Initial
total
count/ml
106 
107
108
Treatment
Undisturbed
Filtered
Centrifuged
Undisturbed
Filtered
Centrifuged
Undisturbed
Filtered
Centrifuged
0 1
6.66 6.74
6.66 6.18
6.66 5.86
8.07 8.36
8.07 6.94
8.07 7.43
8.40 8.26
8.40 8.09
8.40 7.36
Log cfu/ml on day
2 3 4 5 6
7.08 7.18 7.38 8.14 8.20
6.48 6.30 6.89 6.85 6.11
5.30 4.65 4.30 3.78 3.74
8.25 8.05 8.65 8.62 8.67
6.28 7.02 7.22 6.97 6.41
7.10 6.60 5.85 6.40 4.04
8.62 8.50 8.59 8.60 8.72
6.27 7.08 6.81 6.80 5.83
6.52 5.81 5.44 5.30 6.41
Results
The experiment to compare centrifugation against
filtration for removal of drugs was done using
M.tuberculosis H37Rv at three different initial con-
centrations (6.66, 8.07 and 8.40 log cfu/ml) in dupli-
cate. The results are presented in Table 1. Among the
cultures left undisturbed, the greatest increase in the
log cfu/ml over the six day period was seen in the
culture with initial count of 6.66 log cfu/ml. In the
cultures with higher initial counts (8.07 and 8.40 log
cfu/ml), the net increase over the six day period was
small. Again, in the cultures subjected to filtration
and resuspension every day, there was a net reduction
in the log viable counts over the six day period, and
this reduction was smallest in the cultures with initial
count of 6.6 log cfu/ml. These results indicated that
to examine the effect of pulsed exposures on log
phase cultures, in experimental systems similar to the
one used in the present study, initial counts closer to
6 log cfu/ml would be more suitable. In the cultures
subjected to centrifugation and resuspension also
there was loss of bacilli every day resulting finally in
a greater net loss over the six day period.
The results of the experiment on pulsed exposure
to REmb/IZ and REmbIZ for the 7 strains of
M. tuberculosis are presented in Table 11 and the Fig.
The undisturbed controls (UC) of all the 7 strains
showed more than 1 log increase in the log cfu/ml
over the 6 days, indicating that the cultures were in a
state of active growth. One of these strains (PE7) was
resistant to S, I, R and Emb. Pulsed exposure to
REmb/IZ as well as REmbIZ did not have any bacte-
ricidal activity on this strain, with the log cfu/ml on
day 6 being 6.57 and 6.68 in the REmb/IZ and
REmbIZ treated cultures, respectively, compared to
5.49 on day 0.
With all the other strains, a greater fall in the log cfu/
ml was observed in both the REmb/IZ and REmbIZ
treated cultures compared to the filtered control (FC)
cultures over the 6 day period. In the drug sensitive
strains (PE1, PE2 and PE3), the fall in the log cfu/ml
was 5.08, >4.45 and >3.65 respectively in the REmb/IZ
treated cultures and 5.56, 4.45 and > 3.65 respectively
in the REmbIZ treated cultures, compared to only 0.96,
0.72 and 1.34 respectively in the filtered control cul-
tures. On calculating and comparing the mean AUCs,
in the manner described here, for the log cfu/ml in the
cultures of these drug sensitive strains subjected to
different treatment procedures, it was found that the
differences observed between the cultures treated with
pulsed exposure to REmb/IZ and REmbIZ were not
significant (P >0.05), while those between the filtered
controls and the cultures treated with REmb/IZ and
REmbIZ were significant (P < 0.02). Similarly, in the
3 strains, PE4, PE5 and PE6, which were resistant to
one or more drugs, the fall in the log cfu/ml over the 6
days was > 4.12, > 4.07 and >3.88 respectively in the
REmb/IZ treated cultures and > 4.12, 3.59 and >3.88
respectively in the REmbIZ treated cultures, compared
to only 0.82, 0.17 and 2.71 respectively in the filtered
ontrol cultures. The differences observed in the AUCs
b tween the REmb/IZ and REmbIZ treated cultures
were not significant (P > 0.1), while that between the
filtered controls and the cultures treated with the drugs
were significant (P < 0.05).
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These results suggested that REmbIZ together or
separately as REmb and IZ on alternate days would
have similar bactericidal action on M.tuberculosis
strains.
Table II. Serial viable counts of each strain of M. tuberculosis after
pulsed exposure to REmb/IZ or REmbIZ
Strain Drug sen- Treat- log cfu/ml on day
no. sitivity ment 0 2 4 6
Strains sensitive to S, I and R :
PE1 SIR UC 6.96 6.97 8.14 8.47
sensitive FC 6.96 6.44 6.63 6.00
REmb/IZ 6.96 4.24 2.44 1.88
REmbIZ 6.96 3.18 2.00 1.40
PE2 SIR UC 5.85 6.20 6.94 8.31
sensitive FC 5.85 5.60 4.99 5.13
REmb/IZ 5.85 4.07 2.24 <1.40*
REmbIZ 5.85 3.88 2.10 1.40
PE3 SIR UC 5.05 5.81 5.40 6.09
sensitive FC 5.05 4.81 3.41 3.71
REmb/IZ 5.05 2.40 <1.40* <1.40*
REmbIZ 5.05 <1.40* <1.40* <1.40*
Strains resistant to one or more drugs among S, I rind R :
PE4 I UC 5.52 6.24
resistant FC 5.52 5.63
REmb/IZ 5.52 3.35
REmbIZ 5.52 3.10
PE5 IR UC 5.47 6.21
resistant FC 5.47 5.11
REmb/IZ 5.47 4.48
REmbIZ 5.47 4.60
PE6 SIR UC 5.28 6.08
resistant FC 5.28 4.68
REmb/IZ 5.28 3.57
REmbIZ 5.28 4.01
6.99 7.97
5.44 4.70
<1.40* <1.40*
1.70 <1.40*
7.16 7.98
5.40 5.30
3.40 <1.40*
3.18 1.88
6.11 7.78
3.88 2.57
2.18 <1.40*
2.78 <1.40*
SIREmb resistant strain :
PE7 SIREmb UC 5.49 6.24 6.99 7.97
resistant FC 5.49 4.72 5.51 5.48
REmb/IZ 5.49 6.01 6.51 6.57
REmbIZ 5.49 5.85 6.48 6.68
UC = undisturbed control; FC, filtered control; REma/IZ,
REmb and IZ on alternate days; REmbIZ, REmbIZ together on
alternate days; *, 1.40 was the minimum detectable log cfu/ml
R. rifampicin; Emb, ethambutol; I, isoniazid; Z, pyrazinamide;
S, streptomycin
Discussion
In vitro systems have been used earlier by
Dickinson and Mitchison3,4,8 to examine the choice of
drugs for intermittent chemotherapy of tuberculosis
and the suitability of new rifamycins for intermittent
chemotherapy. The bactericidal effect observed in the
present study may be an indirect measure of the early
bactericidal action of these drugs on the population of
actively growing tubercle bacilli in cavity walls. It is
unlikely to measure the ultimate sterilising activity of
the drugs, as measured by the proportion of negative
sputum cultures at 2 months and the relapse rate after
stopping chemotherapy9.
In the filtration and resuspension method used in
the present study, loss of bacilli occurred during the
6 daily pulses even in the control cultures subjected
to the procedure but not treated with drugs. This loss
of bacilli might have been due to adherence of the
organisms on the filter membranes. However, in the
cultures with drugs, the viable counts fell at a greater
rate over the 6 day period allowing an estimation of
the bactericidal action of the drugs. Preliminary ex-
periments suggested that the loss of bacilli in filtra-
tion could be minimised by using a low initial count,
washing the filter membranes with sterile water and
inclusion of glass beads for resuspension. Even
greater losses of bacilli occurred if drugs were re-
moved by centrifugation and resuspension.
The overall results obtained with the sensitive and
resistant strains, analysed together or separately, indi-
cate that under in vitro conditions, pulsed exposure to
REmb/IZ will have bactericidal action comparaable to
that of all 4 drugs together. Both REmb/IZ and
REmbIZ treatments had equally good bactericidal
action in vitro on M. tuberculosis strains sensitive to
S, I and R and also on strains resistant to one or more
of these drugs. So, splitting up REmbiZ into REmb
and IZ separately on alternative days in SCC rcgimcns
may not affect the bactericidal action of the regimens.
The limitations such as loss of bacilli during filtra-
tion and resuspension, and the possible lack of activ-
ity of pyrazinamide in the in vitro model used in the
present study may be overcome by using mouse peri-
toneal macrophage or human macrophage systeml0-15.
In the macrophage system, it is easy to pulse with
drugs as the cells are stuck to the wells, and
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Fig. Serial viable counts of drug sensitive (n=3) and drug resistant isolates (n=3) of M.
tuberculosis treated with pulsed exposure to REmbIZ or REmb and IZ. R, rifampicin;
Emb, ethambutol; I, isoniazid; Z, pyrazinamide; FC, filtered control; REmb/IZ, treated
with REmb and IZ on alternate days; REmbIZ, treated with REmbIZ together on
alternate days; (sen), M. tuberculosis olates sensitive to S, I and R; (res), M .
tuberculosis i olates resistant to one or more drugs among S, I and R.
pyrazinamide as well as the other drugs are all active
together. The experimental murine tuberculosis model
of Grosset and associates16 is another system which
could be useful. Finally, the relevance of the findings
from these models would depend on pharmacokinetic
data as well as assessments of bactericidal activity in
tuberculosis patients by serial sputum viable count
examinations9.
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